Biologic Outsourcing STREAM
-
Rising To Meet Increasing Demand For Microbial Based Biologics
12/16/2021
The production of your biotherapeutic deserves the reliability and peace of mind that only a trusted and experienced microbial fermentation partner can provide. Ajinomoto Bio-Pharma Services is a recognized leader in recombinant protein, plasmid DNA, and critical raw material manufacturing for vaccine and gene therapy applications.
-
OPTIMA 7000 Fill Line
6/7/2021
Ajinomoto Bio-Pharma Services is a leader in aseptic filling, offering a wide range of capabilities for vials with our OPTIMA 7000 fill line. The OPTIMA VFVM 7000 safely processes various types and classes of biopharmaceutical products in 2 mL to 100 mL sizes.
-
The BlazarĀ® Platform In A Minute
3/12/2021
The Blazar® Rodent Panel from the BioReliance® portfolio can speed cell line characterization and bulk harvest lot release testing. This degenerate PCR-based method accelerates characterization by reducing timelines by up to 80% and replaces the use of animals.
-
Streamline Your mRNA Purification Steps
3/4/2025
Ensure your mRNA's stability and effectiveness post-transcription with advanced filtration and chromatography techniques to enhance purity and recovery, which delivers high-quality mRNA for superior therapeutics and vaccines.
-
Meet The Experts: Part 1 - Process Analytical Technology (PAT)
5/1/2023
Watch part 1 of this 4-part interview series to learn about process analytical technology (PAT) from expert Stacy Shollenberger.
-
Abzena Capacity Update October 2025: Large Molecule
10/16/2025
Accelerate your therapeutic antibody and complex protein development with advanced mammalian cell line platforms that move from DNA to RCB in just 10 weeks.
-
Meet The Experts: Part 2 - Raman Spectroscopy
5/1/2023
Watch part 2 of this 4-part interview series to explore Raman spectroscopy, one of the main PAT tools for monitoring bioprocess CQAs and CPPs, with expert Fabien Caron.
-
Meet The Experts: Part 3 - Chemometrics And Model Building
5/1/2023
Watch part 3 of this 4-part interview series to learn about chemometrics and model building from expert Johan Cailletaud.
-
MilliporeSigma Bio-Expo Live February 2025: Downstream Bioprocessing
3/17/2025
Advancements in single-use technologies are transforming antibody-drug conjugate manufacturing and offering increased flexibility. Examine key data, design considerations, operational benefits, and applications in ADC production.
-
Abzena Capacity Update October 2025: ADC
10/15/2025
Explore ThioBridge™ as an efficient site-specific conjugation technology to generate ADCs and other conjugate modalities, such as AOCs and conjugates for diagnostic applications.